WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012107498) LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/107498    International Application No.:    PCT/EP2012/052144
Publication Date: 16.08.2012 International Filing Date: 08.02.2012
IPC:
A61K 31/135 (2006.01), A61P 35/02 (2006.01)
Applicants: ORYZON GENOMICS S.A. [ES/ES]; Calle Sant Ferran, 74 E-08940 Cornella de Llobregat - Barcelona (ES) (For All Designated States Except US).
BAKER, Jonathan, Alleman [US/ES]; (ES) (For US Only).
CASTRO PALOMINO, Julio [DE/ES]; (ES) (For US Only).
FYFE, Matthew, Colin, Thor [GB/ES]; (ES) (For US Only).
MAES, Tamara [BE/ES]; (ES) (For US Only).
MARTINELL PEDEMONTE, Marc [ES/ES]; (ES) (For US Only)
Inventors: BAKER, Jonathan, Alleman; (ES).
CASTRO PALOMINO, Julio; (ES).
FYFE, Matthew, Colin, Thor; (ES).
MAES, Tamara; (ES).
MARTINELL PEDEMONTE, Marc; (ES)
Agent: MEIER, Jürgen; Vossius & Partner Siebertstraße 4 81675 München (DE)
Priority Data:
61/462,881 08.02.2011 US
Title (EN) LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE DISORDERS
(FR) INHIBITEURS DE LYSINE DIMÉTHYLASE POUR DES TROUBLES MYÉLOPROLIFÉRATIFS
Abstract: front page image
(EN)The invention relates to methods and compositions for the treatment or prevention of diseases and disorders associated with myeloproliferative disorders. In particular, the invention relates to an LSD 1 inhibitor for use in treating or preventing Philadelphia chromosome negative myeloproliferative disorders.
(FR)L'invention concerne des méthodes et des compositions pour le traitement ou la prévention de maladies et de troubles associés à des troubles myéloprolifératifs. En particulier, l'invention concerne un inhibiteur de LSD 1 pour l'utilisation dans le traitement ou la prévention de troubles myéloprolifératifs négatifs du chromosome de Philadelphie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)